Toward Localized In Vivo Biomarker Concentration Measurements
暂无分享,去创建一个
Krishnamurthy V. Nemani | J. Weaver | I. Perreard | S. Fiering | D. Reeves | Xiaojuan Zhang | B. Gimi | Yipeng Shi | S. Toraya-Brown
[1] John B Weaver,et al. Magnetic nanoparticle sensing: decoupling the magnetization from the excitation field , 2014, Journal of physics D: Applied physics.
[2] Barjor Gimi,et al. Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion. , 2013, Biosensors & bioelectronics.
[3] P. J. Hoopes,et al. Noninvasive assessment of magnetic nanoparticle-cancer cell interactions. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[4] C. Bertozzi,et al. Real-time noninvasive imaging of fatty acid uptake in vivo. , 2012, ACS chemical biology.
[5] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[6] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[7] H. C. Yang,et al. Universal Behavior of Biomolecule-Concentration-Dependent Reduction in AC Magnetic Susceptibility of Bioreagents , 2012, IEEE Magnetics Letters.
[8] M. Cima,et al. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers , 2011, Nature Biotechnology.
[9] John B Weaver,et al. Concurrent quantification of multiple nanoparticle bound states. , 2011, Medical physics.
[10] John B. Weaver,et al. Measurement of molecular binding using the Brownian motion of magnetic nanoparticle probes , 2010 .
[11] Krishnamurthy V. Nemani,et al. Cell encapsulation and oxygenation in nanoporous microcontainers , 2009, Biomedical microdevices.
[12] Frank Ludwig,et al. Binding assays with streptavidin-functionalized superparamagnetic nanoparticles and biotinylated analytes using fluxgate magnetorelaxometry , 2009 .
[13] Barjor Gimi,et al. A Nanoporous, Transparent Microcontainer for Encapsulated Islet Therapy , 2009, Journal of diabetes science and technology.
[14] Thomas Ming-Hung Lee,et al. Over-the-Counter Biosensors: Past, Present, and Future , 2008, Sensors.
[15] T. Okazaki,et al. PD-1 and PD-1 ligands: from discovery to clinical application. , 2007, International immunology.
[16] Eunkeu Oh,et al. Magnetophoretic immunoassay of allergen-specific IgE in an enhanced magnetic field gradient. , 2007, Analytical chemistry.
[17] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[18] Weiping Zou,et al. Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.
[19] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[20] R K Jain,et al. Direct in vivo measurement of targeted binding in a human tumor xenograft. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] H. Barr,et al. Medical applications of Raman spectroscopy: from proof of principle to clinical implementation. , 2002, Biopolymers.